X
Xenon Pharmaceuticals Inc
SWB:XP0
Xenon Pharmaceuticals Inc
SWB:XP0
Price:
48.2
EUR
-3.6%
Market Closed
Market Cap:
€1.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
X
|
Xenon Pharmaceuticals Inc
SWB:XP0
|
CA |
|
Omnicell Inc
NASDAQ:OMCL
|
US |
|
T
|
Tourmaline Oil Corp
F:08T
|
CA |
|
M K Proteins Ltd
BSE:543919
|
IN |
|
E
|
Endesa SA
XMUN:ENA
|
ES |
|
Trade Desk Inc
BMV:TTD
|
US |
|
T
|
Temenos AG
XBER:TE8N
|
CH |
|
B
|
Bradda Head Lithium Limited
OTC:BHLIF
|
IM |
|
S
|
SSE PLC
XMUN:SCT
|
UK |
|
Keppel Corporation Ltd
OTC:KPELF
|
SG |
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
AU |
|
G
|
Garmin Ltd
F:GEY
|
CH |
|
Eenergy Group PLC
LSE:EAAS
|
UK |
|
De' Longhi SpA
F:DLN
|
IT |
|
W
|
Weibo Corp
XMUN:2WBA
|
CN |
|
Straumann Holding AG
F:QS51
|
CH |
|
C
|
Constellation Brands Inc
XMUN:CB1A
|
US |
|
APG SGA SA
F:279
|
CH |
|
Ondas Holdings Inc
F:1B8
|
US |
|
T
|
TechTarget Inc
XBER:EFT
|
US |
|
Orkla ASA
OTC:ORKLF
|
NO |
|
S
|
Sugi Holdings Co Ltd
F:UGI
|
JP |
Wall St Price Targets
XP0 Price Targets Summary
Xenon Pharmaceuticals Inc
Xenon Pharmaceuticals Inc
Wall Street analysts forecast XP0 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for XP0 is 68.92 EUR with a low forecast of 42.74 EUR and a high forecast of 88.87 EUR.
Lowest Forecast
Price Target
42.74
EUR
11% Downside
Average Forecast
Price Target
68.92
EUR
43% Upside
Highest Forecast
Price Target
88.87
EUR
84% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is XP0's stock price target?
Price Target
68.92
EUR
68.92
EUR
According to Wall Street analysts, the average 1-year price target for XP0 is 68.92 EUR with a low forecast of 42.74 EUR and a high forecast of 88.87 EUR.
What is the Revenue forecast for Xenon Pharmaceuticals Inc?
Projected CAGR
108%
108%
Over the last 13 years, the compound annual growth rate for Revenue has been -5%. The projected CAGR for the next 8 years is 108%.
